Oral hypoglycemic agents: A little teaching makes therapy go a long wayAn abstract is unavailable. This article is available as a PDF only.doi:10.1097/00152193-197508000-00013Gail B. AskewKenneth I. LetcherNursing
Oral/topical NSAID use for at least 3 months. Drug induced hematological disorder History/diagnosis of diabetes. Use of insulin/oral hypoglycemics. Use of a β-adrenergic blocking agent (eg, propranolol, nadolol). Use of fluroquinolones. Diagnosis and/or history of kidney disease. Use of ...
EVALUATION OF THE UTILIZATION OF ORAL HYPOGLYCEMIC DRUGS IN DIABETIC TYPE 2 OUTPATIENT CLINIC OF A TEACHING HOSPITAL IN NORTH INDIADiabetes Mellitus is a metabolic disorder characterized by the presence of hyperglycaemia due to defective insulin secretion, insulin action or both. The estimated number ...